Voyager Therapeutics, Inc. (VYGR)

Voyager Therapeutics Revenue

In the year 2023, Voyager Therapeutics had annual revenue of $250.01M with 511.16% growth. Revenue in the quarter ending December 31, 2023 was $90.06M, a -5,910.39% decrease year-over-year.

• Revenue (ttm): $250.01M
• Revenue Growth: +511.16%
• P/S Ratio: 1.66
• Revenue / Employee: $1,543,259
• Employees: 162
• Market Cap: 413.77M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	250.01M	209.10M	511.16%
Dec 31, 2022	40.91M	3.49M	9.33%
Dec 31, 2021	37.42M	-133.71M	-78.14%
Dec 31, 2020	171.13M	66.74M	63.93%
Dec 31, 2019	104.39M	96.77M	1,270.14%
Dec 31, 2018	7.62M	-2.52M	-24.82%
Dec 31, 2017	10.14M	-4.09M	-28.73%
Dec 31, 2016	14.22M	-3.11M	-17.96%
Dec 31, 2015	17.33M	-	-
Dec 31, 2014	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.